3-158644604-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_024996.7(GFM1):c.-31A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.003 in 1,550,486 control chromosomes in the GnomAD database, including 91 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0045 ( 8 hom., cov: 33)
Exomes 𝑓: 0.0028 ( 83 hom. )
Consequence
GFM1
NM_024996.7 5_prime_UTR
NM_024996.7 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.50
Genes affected
GFM1 (HGNC:13780): (G elongation factor mitochondrial 1) Eukaryotes contain two protein translational systems, one in the cytoplasm and one in the mitochondria. Mitochondrial translation is crucial for maintaining mitochondrial function and mutations in this system lead to a breakdown in the respiratory chain-oxidative phosphorylation system and to impaired maintenance of mitochondrial DNA. This gene encodes one of the mitochondrial translation elongation factors. Its role in the regulation of normal mitochondrial function and in different disease states attributed to mitochondrial dysfunction is not known. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 3-158644604-A-G is Benign according to our data. Variant chr3-158644604-A-G is described in ClinVar as [Benign]. Clinvar id is 137469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-158644604-A-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00445 (678/152332) while in subpopulation EAS AF= 0.0474 (246/5186). AF 95% confidence interval is 0.0426. There are 8 homozygotes in gnomad4. There are 423 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GFM1 | NM_024996.7 | c.-31A>G | 5_prime_UTR_variant | 1/18 | ENST00000486715.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GFM1 | ENST00000486715.6 | c.-31A>G | 5_prime_UTR_variant | 1/18 | 1 | NM_024996.7 | P1 | ||
GFM1 | ENST00000264263.9 | c.-31A>G | 5_prime_UTR_variant | 1/19 | 5 | ||||
GFM1 | ENST00000478576.5 | c.-31A>G | 5_prime_UTR_variant | 1/14 | 2 | ||||
GFM1 | ENST00000478254.5 | c.-31A>G | 5_prime_UTR_variant, NMD_transcript_variant | 1/18 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00445 AC: 678AN: 152214Hom.: 8 Cov.: 33
GnomAD3 genomes
AF:
AC:
678
AN:
152214
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00643 AC: 1010AN: 157050Hom.: 23 AF XY: 0.00589 AC XY: 496AN XY: 84236
GnomAD3 exomes
AF:
AC:
1010
AN:
157050
Hom.:
AF XY:
AC XY:
496
AN XY:
84236
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00284 AC: 3971AN: 1398154Hom.: 83 Cov.: 29 AF XY: 0.00285 AC XY: 1965AN XY: 690134
GnomAD4 exome
AF:
AC:
3971
AN:
1398154
Hom.:
Cov.:
29
AF XY:
AC XY:
1965
AN XY:
690134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00445 AC: 678AN: 152332Hom.: 8 Cov.: 33 AF XY: 0.00568 AC XY: 423AN XY: 74496
GnomAD4 genome
AF:
AC:
678
AN:
152332
Hom.:
Cov.:
33
AF XY:
AC XY:
423
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 04, 2013 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at